30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans. SARS‑CoV‑2 is a strain of the species...
122 KB (12,466 words) - 12:07, 25 May 2024
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are...
228 KB (21,044 words) - 20:05, 14 May 2024
Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South...
207 KB (23,819 words) - 16:45, 15 April 2024
The Delta variant (B.1.617.2) was a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India on 5 October 2020. The Delta...
101 KB (10,984 words) - 22:09, 17 October 2023
respiratory syndrome coronavirus 1 (SARS-CoV-1), previously known as severe acute respiratory syndrome coronavirus (SARS-CoV), is a strain of coronavirus that...
31 KB (3,748 words) - 13:16, 20 January 2024
variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2 (with most estimates...
219 KB (18,220 words) - 23:46, 31 March 2024
Beta variant, (B.1.351), was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be of particular...
72 KB (6,070 words) - 06:39, 3 February 2024
SARS-CoV-1 and SARS-CoV-2. Both of these strains descended from a single ancestor but made the cross-species jump into humans separately. SARS-CoV-2 is...
52 KB (5,878 words) - 23:00, 7 May 2024
variant (P.1) was one of the variants of SARS-CoV-2, the virus that causes COVID-19. This variant of SARS-CoV-2 has been named lineage P.1 and has 17 amino...
60 KB (4,943 words) - 18:26, 28 February 2024
Theta variant, also known as lineage P.3, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. The variant was first identified in the...
13 KB (1,007 words) - 07:42, 3 February 2024
The Lambda variant, also known as lineage C.37, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in Peru in August 2020...
14 KB (1,091 words) - 15:50, 23 March 2024
The term variant of concern (VOC) for SARS-CoV-2, which causes COVID-19, is a category used for variants of the virus where mutations in their spike protein...
12 KB (1,196 words) - 23:56, 17 May 2024
also known as lineage B.1.621 or VUI-21JUL-1, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in Colombia in...
27 KB (2,258 words) - 22:09, 2 November 2023
to two PANGO lineages B.1.427 and B.1.429, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in California,...
13 KB (980 words) - 11:10, 16 January 2024
is a variant of SARS-CoV-2, the virus that causes COVID-19. It is one of the three sublineages of Pango lineage B.1.617. The SARS-CoV-2 Kappa variant is...
20 KB (1,537 words) - 22:05, 3 November 2023
SARS-CoV-2 Zeta variant plotted on a genome map of SARS-CoV-2 with a focus on the spike. A sub-lineage of B.1.1.28 "PANGO lineages Lineage P.2". COV lineages...
4 KB (428 words) - 00:56, 13 October 2023
The Eta variant is a variant of SARS-CoV-2, the virus that causes COVID-19. The Eta variant or lineage B.1.525, also called VUI-21FEB-03 (previously VUI-202102/03)...
9 KB (521 words) - 21:49, 30 January 2024
Iota variant, also known as lineage B.1.526, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in New York City...
10 KB (618 words) - 08:20, 3 March 2024
Transmission of COVID-19 (redirect from Asymptomatic transmission of SARS-CoV-2)
moderate COVID-19 remain infectious (i.e., shed replication-competent SARS-CoV-2) for up to ten days after symptoms begin, although there are few transmission...
67 KB (7,104 words) - 19:10, 19 April 2024
COVID-19 pandemic (redirect from SARS-CoV-2 outbreak)
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identified in an outbreak in Wuhan, the...
372 KB (32,326 words) - 02:24, 21 May 2024
American mink and the European mink have shown high susceptibility to SARS-CoV-2 since the earliest stages of the COVID-19 pandemic, first in mink farms...
11 KB (1,175 words) - 22:20, 13 September 2023
Coronavirus spike protein (redirect from SARS-CoV-2 spike protein)
range of receptors; SARS-CoV (which causes SARS) and SARS-CoV-2 (which causes COVID-19) both interact with angiotensin-converting enzyme 2 (ACE2). The S2 region...
75 KB (7,388 words) - 18:58, 4 May 2024
3C-like protease (redirect from SARS-CoV-2 main protease)
SARS 3C-like protease, SARS coronavirus 3CL protease, SARS coronavirus main peptidase, SARS coronavirus main protease, SARS-CoV 3CLpro enzyme, SARS-CoV...
17 KB (1,650 words) - 05:04, 17 May 2024
Long COVID (redirect from Post-Acute Sequelae of SARS-CoV-2 infection)
SARS-CoV-2 (PASC) refers to ongoing, relapsing, or new symptoms, or other health effects that occur 4 or more weeks after the acute phase of SARS-CoV-2...
70 KB (7,120 words) - 19:38, 14 May 2024
Origin of COVID-19 (redirect from Origins of SARS-CoV-2)
to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Available evidence suggests that the SARS-CoV-2 virus was...
116 KB (13,425 words) - 22:35, 19 May 2024
Betacoronavirus (redirect from Beta-CoV)
A, SARS-CoV-1 and SARS-CoV-2 (the causes of SARS and COVID-19 respectively) of lineage B, and MERS-CoV (the cause of MERS) of lineage C. MERS-CoV is the...
15 KB (1,479 words) - 01:17, 9 March 2024
COVID-19 naming (redirect from Colloquial names of SARS-CoV-2 variants)
causative virus as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) based upon its genetic similarity to the 2003 SARS-CoV. The separation between...
25 KB (2,217 words) - 09:20, 10 May 2024
The 2002–2004 outbreak of SARS, caused by severe acute respiratory syndrome coronavirus (SARS-CoV or SARS-CoV-1), infected over 8,000 people from 30 countries...
64 KB (6,425 words) - 19:08, 20 May 2024
Novavax COVID-19 vaccine (redirect from SARS-CoV-2 rS (NVX-CoV2373))
different SARS-CoV-2s was 90.4% and efficacy against moderate-to-severe disease was 100%. Trials were conducted before the emergence of the SARS-CoV-2 Omicron...
71 KB (5,414 words) - 11:13, 28 May 2024